About the Authors
- Cornelia Schuster
-
Affiliations Department of Oncology, Haukeland University Hospital, Bergen, Norway, Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway
- Hans P. Eikesdal
-
Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway
- Hanne Puntervoll
-
Affiliations Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway
- Jürgen Geisler
-
Affiliations Division of Clinical Medicine and Laboratory Sciences, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Oncology, Akershus University Hospital, Lørenskog, Norway
- Stephanie Geisler
-
Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway
- Daniel Heinrich
-
Affiliations Division of Clinical Medicine and Laboratory Sciences, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Oncology, Akershus University Hospital, Lørenskog, Norway
- Anders Molven
-
Affiliations Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway
- Per E. Lønning
-
Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway
- Lars A. Akslen
-
Affiliations Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway
- Oddbjørn Straume
-
* E-mail: oddbjorn.straume@helse-bergen.no
Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway
Competing Interests
As stated above, the project has received funding from a commercial source (Roche Norway). This includes support for running costs as well as a price reduction for the investigational drug. This study involves Bevacizumab, which is a Roche product. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: OS LA PL. Performed the experiments: CS HE HP JG SG DH OS. Analyzed the data: CS HE HP AM PL LA OS. Contributed reagents/materials/analysis tools: HP AM. Wrote the paper: CS HE HP JG SG DH AM PL LA OS.